Subanesthetic ketamine: an essential adjuvant for intractable cancer pain
Authors:
- Aleksandra Kotlińska-LemieszekAKAleksandra Kotlińska-Lemieszek
- Jacek LuczakJLJacek Luczak
- 1 August 2004
- journal article
- other
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 28 (2) , 100-102
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Ketamine as adjuvant to opioids for cancer pain. a qualitative systematic reviewJournal of Pain and Symptom Management, 2003
- Burst Ketamine to Reverse Opioid Tolerance in Cancer PainJournal of Pain and Symptom Management, 2003
- Translation of symptoms and signs into mechanisms in neuropathic painPain, 2003
- Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapyPain, 2002
- Targeting the N-Methyl-d-Aspartate Receptor for Chronic Pain ManagementJournal of Pain and Symptom Management, 2000
- Mechanisms of hyperalgesian and morphine tolerance: a current view of their possible interactionsPain, 1995
- The Role of Ketamine, an NMDA Receptor Antagonist, in the Management of PainProgress in Palliative Care, 1995